The outcomes of secondary AML post allogeneic hematopoietic cell transplantation significantly depend on the presence of poor-risk cytogenetic abnormalities.
Hassanein M, Fakih RE, Rasheed W, Ahmed S, Shaheen M, Chaudhri N, Alsharif F, Ahmed S, Hanbali A, AlShaibani A, Alfraih F, Alhayli S, Elhassan T, Alahmari A, Alzahrani H, Almohareb F, Aljurf M, Hashmi S.
Hassanein M, et al. Among authors: aljurf m.
EJHaem. 2021 Mar 12;2(2):249-256. doi: 10.1002/jha2.136. eCollection 2021 May.
EJHaem. 2021.
PMID: 35845278
Free PMC article.